Download Sample
Add to CartIntermittent Catheters Market
By Product;
Uncoated Intermittent Catheters and Coated Intermittent Catheters - Antimicrobial Intermittent Catheters, Hydrophilic, Antimicrobial, and OthersBy Indication;
Urinary Incontinence, Spinal Cord Injuries, General Surgery, and OthersBy Category;
Female Length Catheter, Male Length Catheters, and Kid Length CatheterBy End User;
Hospitals, Ambulatory Surgical Centers, and Medical Research CentersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Intermittent Catheters Market Overview
Intermittent Catheters Market (USD Million)
Intermittent Catheters Market was valued at USD 2,333.11 million in the year 2024. The size of this market is expected to increase to USD 3,702.58 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.8%.
Intermittent Catheters Market
*Market size in USD million
CAGR 6.8 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 6.8 % |
| Market Size (2024) | USD 2,333.11 Million |
| Market Size (2031) | USD 3,702.58 Million |
| Market Concentration | Medium |
| Report Pages | 368 |
Major Players
- Coloplast A/S
- Hollister Incorporated
- B. Braun Melsungen AG
- Teleflex Incorporated
- Convatec Group PLC
- C.R. Bard
- Medtronic plc
- Boston Scientific Corporation
- Wellspect Healthcare
- Teleflex Medical OEM
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Intermittent Catheters Market
Fragmented - Highly competitive market without dominant players
The Intermittent Catheters Market is expanding steadily due to the increasing number of patients suffering from urinary retention and bladder dysfunction. Roughly 40% of individuals with spinal injuries depend on these devices, driving steady adoption. This trend is further accelerated by the aging population and a noticeable increase in neurological conditions that hinder natural bladder control.
Innovations Driving Product Preference
Modern intermittent catheters are being enhanced through safer, more comfortable materials. Nearly 55% of users are now opting for hydrophilic-coated types due to reduced friction and improved ease of use. This shift underscores the growing user awareness and the impact of innovation on product selection.
Broader Use Across Care Settings
Usage of intermittent catheters is growing in both clinical and home-based care. Around 62% of patients now manage catheterization outside hospital environments. This transition is helping to reduce hospitalization costs while providing greater independence for users requiring ongoing bladder management.
Supportive Policy and Insurance Landscape
Reimbursement and regulation are vital in expanding access to intermittent catheter products. Roughly 48% of patients benefit from insurance support, enhancing affordability. Policy improvements and faster regulatory clearances are also facilitating product penetration across various healthcare environments.
Intermittent Catheters Market Recent Developments
-
In March 2021, Bactiguard presented results from a published, controlled multicenter study in India, demonstrating that its urinary catheters reduced the risk of catheter-associated urinary tract infections (CAUTI) by 69% compared to standard catheters.
-
In February 2021, UroDev Medical, a medical device company, appointed experienced medical device executive Matt Monarski as its Chief Executive Officer. The company also relocated its headquarters from San Clemente, California, to Minneapolis.
Intermittent Catheters Market Segment Analysis
In this report, the Intermittent Catheters Market has been segmented by Product, Indication, Category, End User, and Geography.
Intermittent Catheters Market, Segmentation by Product
The Intermittent Catheters Market has been segmented by Product into Uncoated Intermittent Catheters and Coated Intermittent Catheters.
Uncoated Intermittent Catheters
Uncoated intermittent catheters currently represent around 40% of the market share. These products are widely used due to their cost-effectiveness and flexibility in lubricant application, making them a preferred choice in resource-limited settings. However, users must manually lubricate them before insertion, which may impact convenience.
Coated Intermittent Catheters
Coated intermittent catheters dominate the segment with a share exceeding 60%, driven by their ease of use and reduced risk of urinary tract infections (UTIs). These catheters often come pre-lubricated or hydrophilic-coated, offering greater comfort and hygiene, particularly for frequent users and in clinical environments.
Intermittent Catheters Market, Segmentation by Indication
The Intermittent Catheters Market has been segmented by Indication into Urinary Incontinence, Spinal Cord Injuries, General Surgery, and Others.
Urinary Incontinence
Urinary incontinence accounts for over 35% of the intermittent catheter market demand. It is especially prevalent among the elderly and patients with neurological disorders. The growing aging population and increasing awareness of bladder management solutions are boosting this segment.
Spinal Cord Injuries
Spinal cord injuries represent around 25% of market usage. Individuals with such injuries often experience neurogenic bladder dysfunction, making intermittent catheterization a critical daily routine. Advances in catheter materials have enhanced user comfort and safety in this group.
General Surgery
The general surgery segment contributes approximately 20% to the market. Catheters are often required post-surgery to manage temporary urinary retention. The demand is driven by rising surgical volumes and the need for short-term catheterization in hospitals.
Others
This segment includes cases such as multiple sclerosis, Parkinson’s disease, and benign prostatic hyperplasia (BPH), together accounting for the remaining 20% share. These conditions often lead to urinary complications requiring intermittent catheter use on a regular basis.
Intermittent Catheters Market, Segmentation by Category
The Intermittent Catheters Market has been segmented by Category into Female Length Catheter, Male Length Catheters, and Kid Length Catheter.
Female Length Catheter
The female length catheter segment accounts for approximately 30% of the total market share. These catheters are typically shorter in length and are designed to match female anatomy. Increasing awareness and improved product accessibility are key growth drivers for this segment.
Male Length Catheters
Male length catheters dominate the market with a share of over 55%, owing to their longer size requirement. They are widely used due to the higher prevalence of urinary disorders among older men. The segment benefits from ongoing innovations in hydrophilic coatings and closed system designs.
Kid Length Catheter
Kid length catheters represent a smaller yet vital share of around 15%. These catheters are specifically designed to suit pediatric anatomy, ensuring safe and gentle insertion. The segment is expanding with growing attention toward pediatric urology care and rising congenital urinary complications.
Intermittent Catheters Market, Segmentation by End User
The Intermittent Catheters Market has been segmented by End User into Hospitals, Ambulatory Surgical Centers, and Medical Research Centers.
Hospitals
Hospitals hold the largest share of the intermittent catheters market at nearly 60%. This dominance is due to the high volume of catheterization procedures, availability of skilled healthcare professionals, and superior post-operative care. The segment continues to grow due to the rise in chronic urinary conditions and surgical admissions globally.
Ambulatory Surgical Centers
Ambulatory Surgical Centers (ASCs) account for around 25% of the market. ASCs offer a cost-effective and faster alternative for outpatient catheterization procedures, making them increasingly popular among patients. The growth of this segment is driven by the trend toward minimally invasive treatments and reduced hospital stays.
Medical Research Centers
Medical Research Centers contribute to approximately 15% of the market. These centers use intermittent catheters for clinical studies, device testing, and trials. Rising R&D investments and collaborations with catheter manufacturers are pushing innovation and expanding this niche but crucial end-user segment.
Intermittent Catheters Market, Segmentation by Geography
In this report, the Intermittent Catheters Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Regions and Countries Analyzed in this Report
Intermittent Catheters Market Share (%), by Geographical Region
North America
North America dominates the intermittent catheters market with a share of nearly 40%, primarily driven by the rising incidence of urinary incontinence, advanced healthcare infrastructure, and strong reimbursement policies. The U.S. leads the region due to high awareness and the adoption of innovative catheter solutions.
Europe
Europe holds around 25% of the global market, supported by favorable government healthcare policies, an aging population, and a high prevalence of neurological disorders. Countries like Germany, France, and the UK are key contributors to the regional demand for intermittent catheter products.
Asia Pacific
Asia Pacific is the fastest-growing market, accounting for approximately 20% share. The surge is attributed to increasing healthcare investments, expanding access to urological care, and growing awareness in countries like China, India, and Japan. The region shows strong growth potential due to its large population base.
Middle East & Africa
Middle East and Africa represent a smaller share, around 8%, yet are gaining traction due to improving healthcare infrastructure and rising chronic disease cases. Government initiatives and the increasing presence of global medical device companies are fostering gradual market growth.
Latin America
Latin America contributes nearly 7% to the global market, with Brazil and Mexico leading in demand. The segment is fueled by growing awareness of intermittent self-catheterization and an increase in healthcare access through public and private sector efforts.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Intermittent Catheters Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers
- Growing aging population globally
- Rising prevalence of urinary disorders
- Technological advancements in products
-
Increasing awareness and healthcare expenditure: The global intermittent catheters market is experiencing significant growth due to increasing awareness and rising healthcare expenditure. Intermittent catheters, designed for patients with urinary retention issues, have become more widely recognized as a crucial tool in managing bladder dysfunction. As public awareness increases through educational campaigns and medical professionals’ efforts to inform patients about the benefits of these devices, demand continues to rise. Additionally, the aging global population, which is more susceptible to urinary incontinence and other related conditions, further drives market expansion.
Healthcare expenditure is another key factor propelling the intermittent catheters market forward. Governments and private sectors worldwide are investing more in healthcare infrastructure and services, recognizing the importance of improving quality of life for individuals with chronic health conditions. These investments lead to better access to medical devices, including intermittent catheters, and foster innovation in the development of more user-friendly and effective products. Enhanced healthcare spending also supports training for healthcare providers, ensuring that they are well-equipped to recommend and instruct patients in the proper use of intermittent catheters.
Technological advancements in catheter design and materials have contributed to market growth. Modern intermittent catheters are becoming more comfortable, easier to use, and less likely to cause infections, which addresses common concerns among patients. Manufacturers are focusing on developing products that offer superior performance and safety features, such as hydrophilic coatings and antibacterial properties. These innovations not only improve patient compliance but also attract a broader consumer base. Consequently, the combination of increased awareness, heightened healthcare expenditure, and technological progress is expected to sustain the upward trajectory of the global intermittent catheters market in the coming years.
Restraints
- High cost of devices
- Risk of urinary tract infections
- Limited reimbursement policies
-
Availability of alternatives: The global intermittent catheters market has experienced significant growth in recent years, driven by factors such as increasing prevalence of urinary incontinence, spinal cord injuries, and neurological disorders. However, one of the key challenges faced by this market is the availability of alternatives. While intermittent catheters are widely used and considered effective in managing bladder dysfunction, there are alternative treatment options that cater to specific patient needs and preferences.
One alternative to intermittent catheterization is indwelling catheters, also known as Foley catheters, which remain in the bladder for an extended period. While indwelling catheters offer convenience by eliminating the need for frequent catheterizations, they are associated with a higher risk of urinary tract infections and other complications. Additionally, some patients may prefer alternative management strategies such as medications, behavioral therapies, or surgical interventions depending on the underlying condition and individual circumstances.
Another emerging alternative in the management of urinary dysfunction is the use of advanced technologies such as sacral neuromodulation and botulinum toxin injections. Sacral neuromodulation involves the implantation of a device that delivers electrical stimulation to the sacral nerves, modulating bladder function and reducing urinary symptoms. Botulinum toxin injections into the bladder wall can also help relax the muscles and improve bladder capacity, particularly in patients with neurogenic bladder conditions. While these alternatives may offer promising outcomes for certain patient populations, they may not be suitable or accessible for all individuals due to factors such as cost, invasiveness, and availability of specialized healthcare services.
Opportunities
- Emerging markets expansion
- Product innovation and development
- Government healthcare initiatives
-
Increasing home healthcare demand: The global intermittent catheters market is experiencing significant growth, primarily fueled by the increasing demand for home healthcare services. As the population ages and the prevalence of urinary retention and incontinence rises, there's a growing need for convenient and effective solutions for managing these conditions. Intermittent catheters have emerged as a vital tool in the management of urinary issues, offering patients a way to empty their bladders comfortably and hygienically.
One of the key drivers behind the rising demand for intermittent catheters is the shift towards home-based healthcare services. With advancements in medical technology and an emphasis on patient-centered care, many individuals prefer receiving treatment in the comfort of their own homes. Intermittent catheters enable patients to perform catheterization independently or with minimal assistance, empowering them to maintain their independence and quality of life while managing their urinary health.
Intermittent catheters play a crucial role in reducing the need for frequent hospital visits or lengthy stays, allowing patients to receive necessary care while minimizing exposure to potential infections. As a result, the global intermittent catheters market is witnessing robust growth, with manufacturers innovating to enhance product features, such as ease of use, comfort, and infection control, to meet the evolving needs of patients and healthcare providers alike.
Competitive Landscape Analysis
Key players in Global Intermittent Catheters Market include:
- Coloplast A/S
- Hollister Incorporated
- B. Braun Melsungen AG
- Teleflex Incorporated
- Convatec Group PLC
- C.R. Bard
- Medtronic plc
- Boston Scientific Corporation
- Wellspect Healthcare
- Teleflex Medical OEM
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Indication
- Market Snapshot, By Category
- Market Snapshot, By End User
- Market Snapshot, By Region
- Intermittent Catheters Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Growing aging population globally
- Rising prevalence of urinary disorders
- Technological advancements in products
- Increasing awareness and healthcare expenditure
- Restraints
- High cost of devices
- Risk of urinary tract infections
- Limited reimbursement policies
- Availability of alternatives
- Opportunities
- Emerging markets expansion
- Product innovation and development
- Government healthcare initiatives
- Increasing home healthcare demand
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Intermittent Catheters Market, By Product, 2021 - 2031 (USD Million)
- Uncoated Intermittent Catheters
- Coated Intermittent Catheters
- Antimicrobial intermittent catheters
- Hydrophilic
- Antimicrobial
- Others
- Intermittent Catheters Market, By Indication, 2021 - 2031 (USD Million)
- Urinary Incontinence
- Spinal Cord Injuries
- General Surgery
- Others
- Intermittent Catheters Market, By Category, 2021 - 2031 (USD Million)
- Female Length Catheter
- Male Length Catheters
- Kid Length Catheter
- Intermittent Catheters Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Medical Research Centers
- Intermittent Catheters Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- North America
- Intermittent Catheters Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Coloplast A/S
- Hollister Incorporated
- B. Braun Melsungen AG
- Teleflex Incorporated
- Convatec Group PLC
- C.R. Bard
- Medtronic plc
- Boston Scientific Corporation
- Wellspect Healthcare
- Teleflex Medical OEM
- Company Profiles
- Analyst Views
- Future Outlook of the Market